• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Summary: Joint Stock Company Zaman-Bank Feb 13

  • ID: 2417598
  • February 2013
  • Standard & Poors

Very strong capital position. The shareholder's commitment to provide funding to ensure business stability and adherence to regulations. Adequate liquidity position, currently with ample liquidity. Weak business position threatened by intensifying competition. Vulnerable risk profile due to high concentrations of the loan book. High reliance on the support of the main shareholder on the funding side and weak diversification of the funding base. The stable outlook reflects our expectation that Joint Stock Company Zaman-Bank will maintain very strong capitalization, balanced against a vulnerable risk profile, concentrated funding, and a marginal competitive position over the next 12 months. We anticipate that profitability will either stabilize or marginally improve, reflecting the bank's efforts to grow new business. We expect moderate growth of...

Companies mentioned in this report are:
- Joint Stock Company Zaman-Bank

Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress READ MORE >

Note: Product cover images may vary from those shown

- Joint Stock Company Zaman-Bank

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.